Intermediate-scale benchtop bioreactor protocol streamlines production of iPSC-derived macrophages for research, drug discovery, and modeling.

Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.

Scientists at the University of California San Francisco (UCSF) are working on a new approach to treating kidney failure that could one day free people from needing dialysis or taking drugs to ...